Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma
Top Cited Papers
- 25 April 2025
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (7) , 419-433
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (R01CA244328, P30CA076292)
This publication has 32 references indexed in Scilit:
- Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphomaBlood Cancer Journal, 2024
- Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-AnalysisTransplantation and Cellular Therapy, 2024
- Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroidsBone Marrow Transplantation, 2024
- Toxicities following CAR-T therapy for hematological malignanciesCancer Treatment Reviews, 2022
- Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell LymphomasTransplantation and Cellular Therapy, 2022
- Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic ReviewTransplantation and Cellular Therapy, 2022
- Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphomaCancer Medicine, 2021
- Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemiaBlood Cancer Journal, 2020
- Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyTransplantation and Cellular Therapy, 2019
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsTransplantation and Cellular Therapy, 2019